0001214659-12-003615.txt : 20120814
0001214659-12-003615.hdr.sgml : 20120814
20120814160111
ACCESSION NUMBER: 0001214659-12-003615
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120630
FILED AS OF DATE: 20120814
DATE AS OF CHANGE: 20120814
EFFECTIVENESS DATE: 20120814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANG CAPITAL MANAGEMENT LLC
CENTRAL INDEX KEY: 0001232621
IRS NUMBER: 680517275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14822
FILM NUMBER: 121032682
BUSINESS ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-200-3830
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
13F-HR
1
c81412113fhr.txt
REPORT FOR THE QUARTER ENDED JUNE 30, 2012
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: June 30, 2012
Check here if Amendment [ ]; Amendment Number: __
This Amendment (Check only one): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Tang Capital Management, LLC
Address: 4747 Executive Drive, Suite 510, San Diego, CA 92121
Form 13F File Number: 28-14822
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Kevin C. Tang
Title: Managing Director of Tang Capital Management, LLC
Phone: 858-200-3830
Signature, Place, and Date of Signing:
/s/ Kevin C. Tang San Diego, CA August 14, 2012
----------------------- ------------------------ -------------------------
[Signature] [City, State] [Date]
Report Type (Check only one.):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
[_] 13F NOTICE. (Check here if no holdings reported are in this report, and all
holdings are reported by other reporting manager(s).)
[_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
List of Other Managers Reporting for this Manager: NONE
FORM 13F SUMMARY PAGE
REPORT SUMMARY:
NUMBER OF OTHER INCLUDED MANAGERS: 1
FORM 13F INFORMATION TABLE ENTRY TOTAL: 30
FORM 13F INFORMATION TABLE VALUE TOTAL: 479,109
(thousands)
LIST OF OTHER INCLUDED MANAGERS:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
1 Kevin C. Tang 28-14818
FORM 13F INFORMATION TABLE
VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE
ALEXZA PHARMACEUTICALS INC COM 015384209 1,712 403,840 SH SOLE 403,840 0 0
AMLYIN PHARMACUETICALS INC COM 032346108 56,129 1,990,400 SH SOLE 1,990,400 0 0
BIOMARIN PHARMACEUTICALS INC NOTE 2.500% 3/29/13 09061GAC5 7,213 3,000,000 PRN SOLE 3,000,000 0 0
BIOSANTE PHARMACEUTICALS INC COM 09065V302 313 122,550 SH SOLE 122,550 0 0
CYCLACEL PHARMACEUTICALS INC PFD CONV EX 6% 23254L207 695 277,993 SH SOLE 277,993 0 0
DENDREON CORP COM 24823Q107 589 79,600 SH SHARED-
DEFINED 1 0 79,600 0
DENDREON CORP NOTE 4.750% 6/15/14 24823QAB3 4,310 4,000,000 PRN SOLE 4,000,000 0 0
DENDREON CORP NOTE 2.875% 1/15/16 24823QAC1 18,348 26,515,000 PRN SOLE 26,515,000 0 0
DEPOMED INC COM 249908104 15,487 2,721,706 SH SOLE 2,721,706 0 0
ENDOCYTE INC COM 29269A102 3,829 465,763 SH SOLE 465,763 0 0
GALECTIN THERAPEUTICS INC W EXP 3/28/17 363225111 21 50,526 SH SOLE 50,526 0 0
HORIZON PHARMA INC COM 44047T109 43 6,084 SH SOLE 6,084 0 0
HUMAN GENOME SCIENCES INC COM 444903108 37,811 2,879,750 SH SOLE 2,879,750 0 0
INTERMUNE INC NOTE 2.500% 9/15/18 45884XAE3 13,099 17,000,000 PRN SOLE 17,000,000 0 0
ISIS PHARMACEUTICALS INC NOTE 2.625% 2/15/27 464337AE4 7,717 7,587,000 PRN SOLE 7,587,000 0 0
MANNKIND CORP COM 56400P201 6,667 2,911,227 SH SOLE 2,911,227 0 0
MANNKIND CORP NOTE 3.750% 12/15/13 56400PAA0 21,784 41,494,000 PRN SOLE 41,494,000 0 0
NAVIDEA BIOPHARMACEUTICALS INC COM 63937X103 3,424 920,481 SH SOLE 920,481 0 0
NEKTAR THERAPEUTICS INC NOTE 3.250% 9/28/12 640268AH1 79,173 78,907,000 PRN SOLE 78,907,000 0 0
NEUROCRINE BIOSCIENCES INC COM 64125C109 3,158 400,000 SH SOLE 400,000 0 0
ONCOGENEX PHARMACEUTICALS INC COM 68230A106 11,197 833,100 SH SOLE 833,100 0 0
ONCOTHYREON INC COM 682324108 4,680 1,000,000 SH SOLE 1,000,000 0 0
PDL BIOPHARMA INC NOTE 2.875% 2/15/15 69329YAA2 43,140 37,474,000 PRN SOLE 37,474,000 0 0
SALIX PHARMACEUTICALS INC COM 795435106 16,332 300,000 SH SOLE 300,000 0 0
SAVIENT PHARMACEUTICALS INC COM 80517Q100 517 958,098 SH SOLE 958,098 0 0
SAVIENT PHARMACEUTICALS INC NOTE 4.750% 2/1/18 80517QAA8 10,419 38,950,000 PRN SOLE 38,950,000 0 0
SAVIENT PHARMACEUTICALS INC PUT 80517Q950 5,942 38,460 SH SOLE 38,460 0 0
SPECTRUM PHARMACEUTICALS INC COM 84763A108 87,305 5,610,867 SH SOLE 5,610,867 0 0
TRANSCEPT PHARMACEUTICALS INC COM 89354M106 7,494 1,208,720 SH SOLE 1,208,720 0 0
VANDA PHARMACEUTICALS INC COM 921659108 10,561 2,400,252 SH SOLE 2,400,252 0 0